Literature DB >> 22109723

Challenges in recruiting Mexican women for cancer genetics research.

Gwendolyn P Quinn1, Jessica Q McIntyre, Susan T Vadaparampil.   

Abstract

Hispanic women often have low participation rates in cancer genetics research. Additionally, Hispanic sub-ethnicities may have varying accrual rates based on unique cultural factors. Hispanic women were recruited through flyers placed in the Tampa Bay Community to participate in an interview about knowledge of hereditary breast and ovarian cancer. The study goal was to recruit 20 women from each Hispanic sub-ethnicity: Puerto Rican, Mexican, and Cuban. This article reports on the difficulty in recruiting Mexican women. One hundred forty-three women called the study hotline to inquire about participation. Seventy-six callers were ineligible for the study. Thirty-four percent (n = 26) of ineligibles were Mexican women; within this group, 62% (n = 16) were unable to participate because they did not know the cancer site of their first degree relative. Inclusion criteria requiring knowledge of family history of cancer for behavioral research may be too stringent. The socio-cultural norms of Mexican families may not include discussions of cancer specifics. This study demonstrates Mexican women may have limited knowledge about their family history of cancer. Considerations of these knowledge limitations should be built into cancer genetics-related research. Referral criteria to assess the risk of hereditary breast and ovarian cancer by cancer genetics professionals are predicated on the patient providing details about cancer within multiple generations of family members, thus, posing a barrier for Mexican women who may have limited knowledge of their family history of cancer.

Entities:  

Year:  2010        PMID: 22109723      PMCID: PMC3186020          DOI: 10.1007/s12687-010-0032-y

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  18 in total

1.  Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors.

Authors:  A R Giuliano; N Mokuau; C Hughes; G Tortolero-Luna; B Risendal; T E Prewitt; W J McCaskill-Stevens
Journal:  Ann Epidemiol       Date:  2000-11       Impact factor: 3.797

Review 2.  Ethnic differences in drug metabolism and toxicity from chemotherapy.

Authors:  Viet Hong Phan; Melissa M Moore; Andrew J McLachlan; Micheline Piquette-Miller; Hongmei Xu; Stephen J Clarke
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-03       Impact factor: 4.481

3.  Let's celebrate human genetic diversity.

Authors:  Bruce T Lahn; Lanny Ebenstein
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

4.  Preferences for hereditary breast and ovarian cancer information among Mexican, Cuban and Puerto Rican women at risk.

Authors:  Gwendolyn P Quinn; Jessica McIntyre; Susan T Vadaparampil
Journal:  Public Health Genomics       Date:  2010-02-12       Impact factor: 2.000

Review 5.  Breast and cervical cancer screening in Hispanic women: a literature review using the health belief model.

Authors:  LaToya T Austin; Farah Ahmad; Mary Jane McNally; Donna E Stewart
Journal:  Womens Health Issues       Date:  2002 May-Jun

6.  If we build it ... will they come?--establishing a cancer genetics services clinic for an underserved predominantly Latina cohort.

Authors:  Charité Ricker; Veronica Lagos; Nancy Feldman; Susan Hiyama; Sue Fuentes; Visanth Kumar; Kelly Gonzalez; Melanie Palomares; Kathleen Blazer; Katrina Lowstuter; Deborah MacDonald; Jeffrey Weitzel
Journal:  J Genet Couns       Date:  2006-12       Impact factor: 2.537

7.  Awareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk Hispanic women: similarities and variations by sub-ethnicity.

Authors:  Susan T Vadaparampil; Jessica McIntyre; Gwendolyn P Quinn
Journal:  J Genet Couns       Date:  2010-08-27       Impact factor: 2.537

Review 8.  Cancer information disclosure in different cultural contexts.

Authors:  Kyriaki Mystakidou; Efi Parpa; Eleni Tsilila; Emmanuela Katsouda; Lambros Vlahos
Journal:  Support Care Cancer       Date:  2004-03       Impact factor: 3.603

9.  Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials.

Authors:  H A Tejeda; S B Green; E L Trimble; L Ford; J L High; R S Ungerleider; M A Friedman; O W Brawley
Journal:  J Natl Cancer Inst       Date:  1996-06-19       Impact factor: 13.506

10.  Differential use of available genetic tests among primary care physicians in the United States: results of a national survey.

Authors:  Alexandra E Shields; Wylie Burke; Douglas E Levy
Journal:  Genet Med       Date:  2008-06       Impact factor: 8.822

View more
  4 in total

1.  Genomic Disparities in Breast Cancer Among Latinas.

Authors:  Filipa Lynce; Kristi D Graves; Lina Jandorf; Charite Ricker; Eida Castro; Laura Moreno; Bianca Augusto; Laura Fejerman; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

2.  Risk terminology in biobanking and genetic research: what's in a name?

Authors:  Gwendolyn P Quinn; Heide Castañeda; Tuya Pal; Janique L Rice; Cathy D Meade; Clement K Gwede
Journal:  Am J Med Genet A       Date:  2013-07-03       Impact factor: 2.802

3.  Improving cancer clinical research and trials with Hispanic populations: training and outreach efforts between Moffitt Cancer Center and the Ponce School of Medicine.

Authors:  Gwendolyn P Quinn
Journal:  Rev Recent Clin Trials       Date:  2014

4.  A Report of the Women's Health Congress Workshop on The Health of Women of Color: A Critical Intersection at the Corner of Sex/Gender and Race/Ethnicity.

Authors:  Jennifer L Plank-Bazinet; Susan G Kornstein; Janine Austin Clayton; Worta McCaskill-Stevens; Lauren Wood; Nakela Cook; Salman M Tajuddin; Gina M Brown; Tamara Harris; Michele K Evans; Lisa Begg; Claudette E Brooks; Leah R Miller; Amy Caroline Mistretta; Terri L Cornelison
Journal:  J Womens Health (Larchmt)       Date:  2016-01       Impact factor: 2.681

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.